Brainstorm Cell Therapeutics Inc. (BCLI)
OTCMKTS · Delayed Price · Currency is USD
0.6900
+0.0600 (9.52%)
May 27, 2026, 3:21 PM EST
Brainstorm Cell Therapeutics Employees
Brainstorm Cell Therapeutics had 20 employees as of December 31, 2025. The number of employees decreased by 7 or -25.93% compared to the previous year.
Employees
20
Change
-7
Growth
-25.93%
Revenue / Employee
n/a
Profits / Employee
-$515,350
Market Cap
7.66M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Orgenesis | 77 |
| NKGen Biotech | 26 |
| Reviva Pharmaceuticals Holdings | 14 |
| Mosaic ImmunoEngineering | 7 |
| Synlogic | 1 |
Brainstorm Cell Therapeutics News
- 7 days ago - Brainstorm Cell Therapeutics Registration statement: Registration filing - Filings
- 9 days ago - BrainStorm Cell Therapeutics Announces Aggregate of $400,000 in Private Placements Priced at Premium to Market - PRNewsWire
- 12 days ago - BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update - PRNewsWire
- 13 days ago - Brainstorm Cell Therapeutics Quarterly report: Q1 2026 - Filings
- 13 days ago - Brainstorm Cell Therapeutics Earnings release: Q1 2026 - Filings
- 2 months ago - BrainStorm Cell Therapeutics Announces Full Year 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 2 months ago - Brainstorm Cell Therapeutics Annual report: Q4 2025 - Filings
- 2 months ago - Brainstorm Cell Therapeutics Earnings release: Q4 2025 - Filings